Alendronate (Fosamax) reduces fracture rates among women with osteoporosis, usually defined as bone mineral density T-scores lower than -2.5. However, the benefit of alendronate in women with ...
Numbers of fractures were similar in all groups. No obvious adverse effects of alendronate emerged during long-term follow-up. During long-term use of alendronate, gains in BMD are preserved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback